Medical News

RSS

Assessing the transmissibility of SARS-CoV-2 variants of concern

A new study investigated and compared the transmissibility of severe acute respiratory syndrome coronavirus-2 variants of concern.

22 Feb 2022

Severity of SARS-CoV-2 infections with Omicron BA.2 variant relative to the BA.1 variant in South Africa

Researchers estimated the clinical severity of the SARS-CoV-2 Omicron BA.2 sublineage relative to the BA.1 variant in South Africa.

22 Feb 2022

Study offers a new, effective therapeutic option against glioblastoma

A study recently accepted for publication in The Journal of Clinical Investigation describes a new and effective therapy to treat glioblastoma: the concomitant use of ADI-PEG20 together with focal brain radiotherapy.

22 Feb 2022

REGEN-COV antibody combination to prevent COVID-19 severity

A new study assessed the effectiveness of REGEN-COV, a combination of casirivimab and imdevimab monoclonal antibodies, in the prevention of COVID-19 disease severity.

22 Feb 2022

Daily activities linked to lower risk of heart disease in older women

Seniors take note, running or brisk walking is not the only way to reduce the risk of heart disease. Simply being "up and about" performing routine activities, referred to as daily life movement, including housework, gardening, cooking and self-care activities like showering can significantly benefit cardiovascular health.

22 Feb 2022

Study provides a potent biparatopic antibody against all SARS-CoV-2 variants of concern

Researchers demonstrated the potent neutralization of SARS-CoV-2 VOCs, including Omicron by the biparatopic human heavy chain variable domain.

22 Feb 2022

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

Researchers conducted a prospective cohort study to determine the prevalence of chemosensory dysfunction in mild to moderate COVID-19 patients in Italy.

22 Feb 2022

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Researchers evaluated the incidences of SARS-CoV-2 reinfections, hospitalizations, and death among the previously infected population of the Abruzzo region in Italy.

22 Feb 2022

Studies continue to prove ivermectin for COVID-19 treatment ineffectual

Researchers from hospitals around Malaysia have been looking into the efficacy of the controversial drug ivermectin as a possible COVID-19 treatment.

22 Feb 2022

Widely utilized SARS-CoV-2 rapid antigen detection tests continue to perform as expected despite Omicron mutations

A recent study evaluated the performance of three at-home COVID-19 rapid antigen tests commonly used in the US against the SARS-CoV-2 Omicron variant.

22 Feb 2022

Lung microbiome alterations and secondary-infections in lethal COVID-19

Researchers examined how an interplay of host and microbial factors weakened immunity leading to secondary infections in COVID-19-infected individuals.

22 Feb 2022

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

On May 13 of last year, the cellphones of thousands of California residents undergoing treatment for chronic pain lit up with a terse text message: "Due to unforeseen circumstances, Lags Medical Centers will be closing effective May 19, 2021."

22 Feb 2022

Covid still threatens millions of Americans. Why are we so eager to move on?

Iesha White is so fed up with the U.S. response to covid-19 that she's seriously considering moving to Europe.

22 Feb 2022

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

Researchers attempted to delineate the duration and stability of anti-SARS-CoV-2 antibodies in patients who had recovered from the COVID-19 infection.

22 Feb 2022

Automata raises US $50 million in series B financing to accelerate automation in life science

Automata – the automation company helping life sciences rapidly innovate, diagnose and discover at scale – today announces it has raised US$50 million in Series B funding.

From Automata 22 Feb 2022

SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021

Researchers examined whether SARS-CoV-2-infected white-tailed deer could be the new animal reservoir with the potential to spillback new SARS-CoV-2 variants into humans.

22 Feb 2022

Spectrum of autoantibodies linked to autoimmune diseases in patients with different COVID-19 clinical outcomes

A broad evaluation of autoimmune disease-associated autoantibodies that have been observed in COVID-19 patients was performed.

22 Feb 2022

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

The current study examined the incidence of COVID-19 in children with ARI relative to other respiratory viruses during the second and third waves.

22 Feb 2022

Time-based sensitivity of COVID-19 serological testing

In a recent study under consideration at Scientific Reports and posted to the Research Square* preprint server, researchers evaluated the impact of time on the sensitivity of four severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) serological assays using samples from the coronavirus disease 2019 (COVID-19) staff testing of antibody responses study(Co-Stars) in the United Kingdom (UK).

22 Feb 2022

Study examines relationship between prenatal and postnatal stress, depression, and infant motor development during COVID

In a recent study posted to the Research Square* preprint server, researchers estimated the impact of antenatal and postnatal maternal mental health on the motor developments of the newborn during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

22 Feb 2022

Medical News

Assessing the transmissibility of SARS-CoV-2 variants of concern

Severity of SARS-CoV-2 infections with Omicron BA.2 variant relative to the BA.1 variant in South Africa

Study offers a new, effective therapeutic option against glioblastoma

REGEN-COV antibody combination to prevent COVID-19 severity

Daily activities linked to lower risk of heart disease in older women

Study provides a potent biparatopic antibody against all SARS-CoV-2 variants of concern

Prevalence of chemosensory loss induced by SARS-CoV-2 Omicron variant in Italy

SARS-CoV-2 reinfection risk in the population of the Abruzzo Region of Italy

Studies continue to prove ivermectin for COVID-19 treatment ineffectual

Widely utilized SARS-CoV-2 rapid antigen detection tests continue to perform as expected despite Omicron mutations

Lung microbiome alterations and secondary-infections in lethal COVID-19

‘Injections, injections, injections’: Troubling questions follow closure of sprawling pain clinic chain

Covid still threatens millions of Americans. Why are we so eager to move on?

Study suggests anti-SARS-CoV-2 antibodies may persist lifelong post-infection

Automata raises US $50 million in series B financing to accelerate automation in life science

SARS CoV-2 in deer from Pennsylvania sampled during fall and winter 2021

Spectrum of autoantibodies linked to autoimmune diseases in patients with different COVID-19 clinical outcomes

SARS-CoV-2 occurrence compared with other respiratory viruses in children with acute respiratory infections

Time-based sensitivity of COVID-19 serological testing

Study examines relationship between prenatal and postnatal stress, depression, and infant motor development during COVID

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News